TW269634B - - Google Patents
Info
- Publication number
- TW269634B TW269634B TW081109192A TW81109192A TW269634B TW 269634 B TW269634 B TW 269634B TW 081109192 A TW081109192 A TW 081109192A TW 81109192 A TW81109192 A TW 81109192A TW 269634 B TW269634 B TW 269634B
- Authority
- TW
- Taiwan
- Prior art keywords
- rgd
- peptide
- administered
- containing peptide
- microcapsules
- Prior art date
Links
- 101000781681 Protobothrops flavoviridis Disintegrin triflavin Proteins 0.000 abstract 3
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000004888 barrier function Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 239000002502 liposome Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000003094 microcapsule Substances 0.000 abstract 1
- 239000004005 microsphere Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 239000003981 vehicle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78923191A | 1991-11-07 | 1991-11-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW269634B true TW269634B (zh) | 1996-02-01 |
Family
ID=25146991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW081109192A TW269634B (zh) | 1991-11-07 | 1992-11-17 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5629294A (zh) |
| EP (1) | EP0667783B1 (zh) |
| AT (1) | ATE179074T1 (zh) |
| AU (1) | AU3064892A (zh) |
| DE (1) | DE69229004D1 (zh) |
| TW (1) | TW269634B (zh) |
| WO (1) | WO1993008818A1 (zh) |
| ZA (1) | ZA928607B (zh) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981719A (en) | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
| US6090925A (en) | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
| DE19529909C2 (de) * | 1995-08-15 | 1998-04-09 | Fresenius Ag | Wässrige Spüllösung |
| EP0793965A3 (en) * | 1996-02-29 | 1999-02-24 | Tano, Yasuo | Prophylactic/therapeutic composition for secondary cataract |
| JP4234803B2 (ja) * | 1997-10-27 | 2009-03-04 | 久光製薬株式会社 | 薬物放出速度が制御された医薬組成物 |
| EP1100558A1 (en) * | 1998-07-24 | 2001-05-23 | Pharmacal Biotechnologies, Inc. | Osseous tissue reconstruction system and method |
| US6730775B1 (en) | 1999-03-23 | 2004-05-04 | University Of Southern California | Methods for limiting scar and adhesion formation |
| US6312725B1 (en) | 1999-04-16 | 2001-11-06 | Cohesion Technologies, Inc. | Rapid gelling biocompatible polymer composition |
| WO2000072856A1 (en) * | 1999-06-01 | 2000-12-07 | Bristol-Myers Squibb Company | Fibrin sealants providing less inflammatory response and methods using same |
| US20010053766A1 (en) * | 2000-02-11 | 2001-12-20 | Janardan Kumar | Method of treating disorders of the eye |
| DE602004026944D1 (de) * | 2003-03-28 | 2010-06-10 | Fujifilm Mfg Europe Bv | RGD-angereicherte gelatineähnliche Proteine zur Verhinderung der Blutplättchenaggregation |
| WO2005053683A1 (en) * | 2003-11-26 | 2005-06-16 | Duke University | A method of preventing or treating glaucoma |
| WO2006078282A2 (en) | 2004-04-28 | 2006-07-27 | Angiotech Biomaterials Corporation | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| CN101379082A (zh) | 2006-01-19 | 2009-03-04 | 爱吉恩公司 | 治疗血管相关疾病的包含肽的药物组合物 |
| WO2007083949A1 (en) * | 2006-01-19 | 2007-07-26 | Eyegene Inc. | Pharmaceutical composition for treating vascular-related diseases comprising peptide |
| US9101581B2 (en) | 2008-10-27 | 2015-08-11 | Eyegene Inc. | Method for treating vascular-related disease |
| AU2008297906A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of the peptide Phpfhlfvy (Renin inhibitor) as a therapeutic agent |
| AU2008297935A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a RGD-peptide and/or parathyroid hormone (1-34 ) as anti-HIV agent |
| CA2698974A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| RU2010113977A (ru) * | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | Применение антагониста рецептора фибриногена и/или пептид фолликулярного гонадолиберина в качестве терапевтического средства при лечении инфекции streptococcus pneumoniae |
| US20110250284A1 (en) * | 2008-06-24 | 2011-10-13 | Lavik Erin B | Nanoparticles for Use as Synthetic Platelets and Therapeutic Agent Delivery Vehicles |
| US9555071B2 (en) * | 2012-06-13 | 2017-01-31 | Thien Nguyen | Methods and compositions for the treatment of axonal and neuronal degeneration |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4517686A (en) * | 1982-08-04 | 1985-05-21 | La Jolla Cancer Research Foundation | Polypeptide |
| US4792525A (en) * | 1982-08-04 | 1988-12-20 | La Jolla Cancer Research Foundation | Tetrapeptide |
| US4589881A (en) * | 1982-08-04 | 1986-05-20 | La Jolla Cancer Research Foundation | Polypeptide |
| US4661111A (en) * | 1982-08-04 | 1987-04-28 | La Jolla Cancer Research Foundation | Polypeptide |
| US4614517A (en) * | 1982-08-04 | 1986-09-30 | La Jolla Cancer Research Foundation | Tetrapeptide |
| US4578079A (en) * | 1982-08-04 | 1986-03-25 | La Jolla Cancer Research Foundation | Tetrapeptide |
| US4746508A (en) * | 1983-06-06 | 1988-05-24 | Beth Israel Hospital Assn. | Drug administration |
| US5352664A (en) * | 1986-10-31 | 1994-10-04 | Board Of Regents, The University Of Texas System | Thrombin derived polypeptides; compositions and methods for use |
| DE3781263T2 (de) * | 1986-12-15 | 1993-04-08 | Inst Nat Sante Rech Med | Peptid-derivate und deren verwendung in der therapie. |
| US4857508A (en) * | 1987-12-03 | 1989-08-15 | Monsanto Company | Novel platelet-aggregation inhibitor peptide derivatives |
| JPH02240020A (ja) * | 1989-01-26 | 1990-09-25 | Childrens Medical Center Corp:The | 外科的切除後の腫瘍再発阻止剤 |
| NZ235564A (en) * | 1989-10-13 | 1993-10-26 | Merck & Co Inc | Fibrinogen receptor antagonist and pharmaceutical compositions |
| NZ235563A (en) * | 1989-10-13 | 1993-04-28 | Merck & Co Inc | Fibrinogen receptor antagonist and pharmaceutical composition |
| US5169833A (en) * | 1989-12-15 | 1992-12-08 | G. D. Searle & Co. | Substituted cyclic pentapeptides |
-
1992
- 1992-11-06 WO PCT/US1992/009494 patent/WO1993008818A1/en not_active Ceased
- 1992-11-06 AU AU30648/92A patent/AU3064892A/en not_active Abandoned
- 1992-11-06 AT AT92924282T patent/ATE179074T1/de not_active IP Right Cessation
- 1992-11-06 EP EP92924282A patent/EP0667783B1/en not_active Expired - Lifetime
- 1992-11-06 DE DE69229004T patent/DE69229004D1/de not_active Expired - Lifetime
- 1992-11-09 ZA ZA928607A patent/ZA928607B/xx unknown
- 1992-11-17 TW TW081109192A patent/TW269634B/zh active
-
1994
- 1994-01-06 US US08/178,482 patent/US5629294A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0667783B1 (en) | 1999-04-21 |
| US5629294A (en) | 1997-05-13 |
| DE69229004D1 (de) | 1999-05-27 |
| EP0667783A1 (en) | 1995-08-23 |
| AU3064892A (en) | 1993-06-07 |
| ATE179074T1 (de) | 1999-05-15 |
| EP0667783A4 (en) | 1995-04-25 |
| WO1993008818A1 (en) | 1993-05-13 |
| ZA928607B (en) | 1993-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW269634B (zh) | ||
| WO1996007397A3 (en) | Delivery of solid drug compositions | |
| CA2102429A1 (en) | Bone growth factors and inhibitors of bone resorption for promoting bone formation | |
| FI945912A0 (fi) | Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö | |
| IL119627A0 (en) | Controlled-release pharmaceutical preparations | |
| CA2195119A1 (en) | Formulations and methods for providing prolonged local anesthesia | |
| CA2203033A1 (en) | Compounds and compositions for delivering active agents | |
| CA2271750A1 (en) | Prolonged anesthesia in joints and body spaces | |
| DK0600079T3 (da) | Oral 1alpha-hydroxyprævitamin D | |
| DE69705746D1 (de) | Injizierbare depotgelzubereitung und herstellungsverfahren | |
| DK0754034T3 (da) | Brusende farmaceutiske formuleringer indeholdende biologisk nedbrydelige mikrokapsler med kontrolleret afgivelse | |
| ATE167800T1 (de) | Polymeres arzneimittelabgabesystem | |
| NZ333724A (en) | Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions | |
| NO305581B1 (no) | Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose | |
| TW228474B (zh) | ||
| GR3026564T3 (en) | Use of sustained-release compositions containing GnRH, LHRH or derivatives thereof | |
| ZA898667B (en) | Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment | |
| ES2111163T3 (es) | Uso de fosfonatos para el tratamiento de la osteoporosis. | |
| CA2156481A1 (en) | 5-ht2 receptor antagonist compositions useful in treating venous conditions | |
| FR2686250B1 (zh) | ||
| ATE289506T1 (de) | Hemmung der tnf-aktivität mit zusammensetzungen enthaltend heparin und lösliche tnf rezeptoren | |
| IL126175A0 (en) | Method or treating heart failure with endothelin antagonists and pharmaceutical compositions containing the same | |
| Skuba et al. | Results of the effect of embolisms, saturated with methotrexate, on intravascular implantation | |
| Kreuz et al. | Behandlung der Hemmkörperhämophilie im Kindesalter | |
| Kovács et al. | Vasopressin and Hemostasis |